Neptune Ice Patch

Manufacturer
Neptune Products L.L.C.
Effective date
2021-04-01
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 22:47:58

Label at a glance#

ProductNeptune Ice Patch
Active ingredientCAMPHOR (NATURAL), DIMETHICONE, LIDOCAINE, MENTHOL
Label structure15 sections

Indications and uses

For the temporary relief of joint pain and muscle pain associated with: Arthritis Backache Cramps Discomfort Neckache Soreness Sprains Strains

Dosage and administration

Ad ults and Children 12 years of Age and Older: Clean and dry the affected area Apply product directly to your skin, up to 4 times daily

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Methemoglobinemia

Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended.

Signs and symptoms of methemoglobinemia may occur immediately or may be delayed some hours after exposure and are characterized by a cyanotic skin discoloration and abnormal coloration of the blood. Methemoglobin levels may continue to rise; therefore, immediate treatment is required to avert more serious central nervous system and cardiovascular adverse effects, including seizures, coma, arrhythmias, and death. Discontinue lidocaine-containing products and any other oxidizing agents. Depending on the severity of the symptoms, patients may respond to supportive care, i.e., oxygen therapy, hydration. More severe symptoms may require treatment with methylene blue, exchange transfusion, or hyperbaric oxygen.

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

Purpose

OTC - PURPOSE SECTION

Topical Anesthetic

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Menthol 1%

Purpose

OTC - PURPOSE SECTION

Topical Analgesic

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Camphor 3%

Purpose

OTC - PURPOSE SECTION

Topical Analgesic

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Dimethicone 3%

Purpose

OTC - PURPOSE SECTION

Skin Conditioner

Uses:

INDICATIONS & USAGE SECTION

For the temporary relief of joint pain and muscle pain associated with:

  • Arthritis
  • Backache
  • Cramps
  • Discomfort
  • Neckache
  • Soreness
  • Sprains
  • Strains

Warnings

WARNINGS SECTION

For External Use Only

Flammable

SPL UNCLASSIFIED SECTION

Keep away from excessive heat or open flame

Do Not Use

OTC - DO NOT USE SECTION

  • On damaged or irritated skin
  • With a bandage or heating pad
  • If you are allergic to any ingredients in this product
  • Other than as directed

When Using This Product

OTC - WHEN USING SECTION

Avoid contact with the eyes

Stop Use and Ask a Doctor If

OTC - ASK DOCTOR SECTION

  • Condition worsens
  • Excessive skin irritation develops
  • Symptoms persist for more than 7 days, or symptoms clear up and occur again within 3 days

If You Are Pregnant or Breast Feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

Ask a health professional before use

Keep Out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If ingested, seek medical help or contact a Poison Control Center immediately

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and Children 12 years of Age and Older:

  • Clean and dry the affected area
  • Apply product directly to your skin, up to 4 times daily

Other Information

SPL UNCLASSIFIED SECTION

  • Store in a cool, dry place with lid tightly closed

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Aloe Barbadensls Leaf Extract, Alcohol, Arnlca Montana Flower Extract, Boswellia Serrata Extracl Butylene Glycol Cellulose Gum Dihydroxyaluminum Aminoecstete, Blycerin, lsopropyl Myristate, Msttwlsulfonylmethene, Partially Neutralized Polyacrylate, Phenoxvethanol, Polvsorbate 80, Porvvinyl Pyrrolidone, Propylene Glycol, Tartaric Acid, Tetrasodium EDTA, Water.

Questions or Comments?

OTC - QUESTIONS SECTION

Info@neptuneice.cool

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

neptunepatchboxneptunepatchbox

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72594-1847-82024-12-30C16284748780-1f386c64a-1d64-0266-e053-dadaa90a7c1aNeptune Ice Patch
72594-1847-82023-01-30C16284748780-1f386c64a-1d64-0266-e053-dadaa90a7c1aNeptune Ice Patch

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72594-1847-8EA - Each72594-18470588b837-f7ca-43a4-bf25-50180976d50912019-08-06

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 25 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72594-184772594-1847-8

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2a83cb8f-eea0-2e45-e063-6394a90a736586acfc88-2322-b097-e053-2a91aa0a032f2024-12-30WarningsExact identifier
spl set id: 86acfc88-2322-b097-e053-2a91aa0a032f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.